Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125450843 | 12545084 | 3 | F | 20160829 | 20160711 | 20160908 | EXP | US-JNJFOC-20160703865 | PHARMACYCLICS | 0.00 | E | M | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125450843 | 12545084 | 1 | SS | IMBRUVICA | IBRUTINIB | 1 | Oral | N | N | 0 | 420 | MG | CAPSULE | QD | |||||
| 125450843 | 12545084 | 2 | PS | IMBRUVICA | IBRUTINIB | 1 | Oral | N | N | 205552 | 420 | MG | CAPSULE | QD | |||||
| 125450843 | 12545084 | 3 | SS | COUMADIN | WARFARIN SODIUM | 1 | U | 0 | |||||||||||
| 125450843 | 12545084 | 4 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 5 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 6 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 7 | C | MUCINEX | GUAIFENESIN | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 8 | C | PROSCAR | FINASTERIDE | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 9 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 10 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 11 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 12 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 13 | C | CARAFATE | SUCRALFATE | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 14 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 15 | C | VALACYCLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 16 | C | RITUXIMAB | RITUXIMAB | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 17 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | ||||||||||||
| 125450843 | 12545084 | 18 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125450843 | 12545084 | 1 | Chronic lymphocytic leukaemia |
| 125450843 | 12545084 | 2 | Chronic lymphocytic leukaemia |
| 125450843 | 12545084 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125450843 | 12545084 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125450843 | 12545084 | Blood viscosity decreased | |
| 125450843 | 12545084 | Fluid retention | |
| 125450843 | 12545084 | Malaise | |
| 125450843 | 12545084 | Pruritus | |
| 125450843 | 12545084 | Skin discolouration | |
| 125450843 | 12545084 | Soft tissue haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125450843 | 12545084 | 1 | 20140311 | 201607 | 0 | |
| 125450843 | 12545084 | 2 | 20160802 | 0 |